6PZ6 image
Entry Detail
PDB ID:
6PZ6
Keywords:
Title:
Co-assembly of VIQKI D452(beta-L-homoaspartic acid) with human parainfluenza virus type 3 (HPIV3) fusion glycoprotein N-terminal heptad repeat domain
Biological Source:
PDB Version:
Deposition Date:
2019-07-31
Release Date:
2020-08-05
Method Details:
Experimental Method:
Resolution:
1.70 Å
R-Value Free:
0.25
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Fusion glycoprotein F1
Chain IDs:A, C, E
Chain Length:53
Number of Molecules:3
Biological Source:Human parainfluenza 3 virus (strain Wash/47885/57)
Polymer Type:polypeptide(L)
Description:VIQKI D4(beta-L-homoaspartic acid) synthetic peptid derived from Fusion glycoprotein F1e
Mutations:D452(beta-L-homoaspartic acid), E459V, A463I, D466Q, Q479K, K480I
Chain IDs:B, D, F
Chain Length:38
Number of Molecules:3
Biological Source:Human parainfluenza 3 virus (strain Wash/47885/57)
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
B3D B ASP modified residue
Primary Citation
Effects of Single alpha-to-beta Residue Replacements on Recognition of an Extended Segment in a Viral Fusion Protein.
Acs Infect Dis. 6 2017 2022 (2020)
PMID: 32692914 DOI: 10.1021/acsinfecdis.0c00385

Abstact

Partial replacement of α-amino acid residues with β-amino acid residues has been established as a strategy for preserving target-engagement by helix-forming polypeptides while altering other properties. The impact of β-residue incorporation within polypeptides that adopt less regular conformations, however, has received less attention. The C-terminal heptad repeat (HRC) domains of fusion glycoproteins from pathogenic paramyxoviruses contain a segment that must adopt an extended conformation in order to coassemble with the N-terminal heptad repeat (HRN) domain in the postfusion state and drive a merger of the viral envelope with a target cell membrane. Here, we examine the impact of single α-to-β substitutions within this extended N-terminal segment of an engineered HRC peptide designated VIQKI. Stabilities of hexameric coassemblies formed with the native human parainfluenza virus 3 (HPIV3) HRN have been evaluated, the structures of five coassemblies have been determined, and antiviral efficacies have been measured. Many sites within the extended segment show functional tolerance of α-to-β substitution. These results offer a basis for future development of paramyxovirus infection inhibitors with novel biological activity profiles, possibly including resistance to proteolysis.

Legend

Protein

Chemical

Disease

Primary Citation of related structures